265 related articles for article (PubMed ID: 4973613)
1. [Behavior of erythrocytic and plasmatic neuraminic acid in newborn infants with Rh and ABO hemolytic disease].
Ambrosioni G; Serritelli G
Clin Pediatr (Bologna); 1968 Sep; 50(9):540-6. PubMed ID: 4973613
[No Abstract] [Full Text] [Related]
2. [Thin-layer chromatography of total lipids in hemolytic disease of the newborn (Rh and ABO). 3. Principal lipid fractions in the erythrocyte in toto in the erythrocytic stroma].
Salvioli GP; Ambrosioni G; Allocca G
Clin Pediatr (Bologna); 1968 Dec; 50(12):926-31. PubMed ID: 4979138
[No Abstract] [Full Text] [Related]
3. [The dynamics of serum-free amino acid concentration in newborn infants with hemolytic disease].
Egorova AI; Aksenova NM
Vopr Okhr Materin Det; 1972 Jan; 17(1):87-8. PubMed ID: 4629897
[No Abstract] [Full Text] [Related]
4. [Erythrocyte sedimentation and clinical findings in newborn infants with hemolytic disease].
Maszkiewicz W; Irzyńska D
Pediatr Pol; 1977 May; 52(5):503-6. PubMed ID: 407544
[No Abstract] [Full Text] [Related]
5. [Thin layer chromatography of the total lipids in hemolytic disease of the newborn (Rh and ABO). 1. Principal lipid fractions in the plasma and quantitative determination of lipemia].
Salvioli GP; Allocca G; Ambrosioni G
Clin Pediatr (Bologna); 1968 Oct; 50(10):645-53. PubMed ID: 4988028
[No Abstract] [Full Text] [Related]
6. [Aspect of reticulocytes and erythroblasts studied by fluorescence microscopy in hemolytic disease of the newborn caused by autoantibodies and isoantibodies. II. Reticulocytes in hemolytic disease of the newborn caused by Rh and ABO incompatibility].
Lombardo G; Infortuna M; Franchina A
Boll Soc Ital Biol Sper; 1975 Dec; 51(24):2005-11. PubMed ID: 821502
[No Abstract] [Full Text] [Related]
7. [Blood lactate dehydrogenase activity in newborns with hemolytic disease due to Rh and ABO-incompatibility].
Dobronravov AV
Vopr Okhr Materin Det; 1969 Jan; 14(1):33-8. PubMed ID: 4976718
[No Abstract] [Full Text] [Related]
8. [Characteristics of determination of the blood groups and Rh factors after exchange transfusions in newborn infants].
Avdeeva RA; Kopp VD; Vasil'eva AF
Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):7-12. PubMed ID: 417341
[No Abstract] [Full Text] [Related]
9. [Complications arising in hemolytic disease of newborn].
Maskiewicz W; Ornat K; Ziemniak J
Pediatr Pol; 1977 Mar; 52(3):293-8. PubMed ID: 403504
[No Abstract] [Full Text] [Related]
10. [Studies on the lipid metabolism of fetal erythroblastosis Rh and ABO. Non-esterified plasma fatty acids and gas chromatographic fractionation of plasma and erythrocyte fatty acids].
Salvioli GP; Ambrosioni G; Allocca G
Haematologica; 1968; 53(7):534-55. PubMed ID: 4976852
[No Abstract] [Full Text] [Related]
11. [Action of various substrates on the spontaneous in vitro hemolysis of erythrocytes in hemolytic disease of the Rh and ABO newborn infant].
Schettini F; Violante N; Mautone A
Minerva Pediatr; 1969 Feb; 21(5):186-90. PubMed ID: 4975718
[No Abstract] [Full Text] [Related]
12. [Study of the acetylcholinesterase activity of the erythrocytes in hemolytic disease of the newborn].
Sirchia G; Ferrone S; Milani R; Masera G
Haematol Lat; 1966; 9(3):215-20. PubMed ID: 4966138
[No Abstract] [Full Text] [Related]
13. Phospholipids of red cells and blood plasma in adults, newborn infants, and patients with Rh erythroblastosis.
Hürter P; Schröter W; Schedel I; Gercken G
Pediatrics; 1970 Aug; 46(2):259-66. PubMed ID: 5464557
[No Abstract] [Full Text] [Related]
14. Investigation of the kinetic characteristics of red blood cell acetylcholinesterase in ABO, Rh hemolytic disease of the newborn and thalassemia major cases.
Ozand P; Artvinli S; Yarimağan S
Turk J Pediatr; 1970; 12(1):1-7. PubMed ID: 4992911
[No Abstract] [Full Text] [Related]
15. [Materno-fetal incompatibility in the ABO system as a factor of protection against hemolytic disease caused by Rh incompatibility].
Mollica F
Minerva Pediatr; 1967 Mar; 19(13):610-1. PubMed ID: 4963996
[No Abstract] [Full Text] [Related]
16. [A case of a newborn infant with erythrocytes sensitized by anti-A 1 antibodies and absence of hematological and clinical findings of hemolytic disease].
Scoppetta V
Arch Ostet Ginecol; 1968; 73(3):391-6. PubMed ID: 4987886
[No Abstract] [Full Text] [Related]
17. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
Osborn LM; Lenarsky C; Oakes RC; Reiff MI
Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
[TBL] [Abstract][Full Text] [Related]
18. [Incidence of Rh and ABO in hemolytic disease of newborn from 1979 to the present day in infants born at the Obstetrics Clinic of the II College of Medicine and Surgery of Naples].
Cascioli CF; Longo G; Capasso A; Grisolia G; Apicella C; Capasso A; Tarabuso A; Liguori G
Minerva Ginecol; 1985 Mar; 37(3):85-8. PubMed ID: 3927200
[No Abstract] [Full Text] [Related]
19. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
Di Piero G; Mencarini L; Ottaviano S; Lapi AS
Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
[No Abstract] [Full Text] [Related]
20. [The activity of glucose-6-phosphate dehydrogenase and of transketolase in the erythrocytes in hemolytic disease of the newborn].
Kovalev IuR
Vopr Okhr Materin Det; 1968 Jan; 13(1):9-13. PubMed ID: 4976082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
